The neurological features of early and 'latent' human immunodeficiency virus infection. 1989

B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
AIDS unit, St Vincent's Hospital, Sydney, NSW, Australia.

Neurological manifestations of unknown cause occurring in patients who become or are HIV antibody positive with presumed normal immune function have been described recently. This report adds a further six cases, all of whom had normal CD4+ cell counts either throughout the period of observation or after the episode of seroconversion. Three had an acute presentation, two in the context of documented seroconversion consisting of one of the following: an encephalitis, an ataxia, and confusion with neuralgic amyotrophy. Three had a subacute disorder occurring at a later phase of HIV infection but before opportunistic infections or neoplasms, and marked by a static mild cognitive deficit. This report extends the range of abnormalities that may be seen at seroconversion and documents the presence of a non-progressive cognitive deficit occurring in the latent phase of HIV infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D004660 Encephalitis Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition. Inflammation, Brain,Rasmussen Syndrome,Brain Inflammation,Encephalitis, Rasmussen,Rasmussen Encephalitis,Rasmussen's Syndrome,Brain Inflammations
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
January 1988, Annals of neurology,
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
January 1992, Medicina clinica,
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
March 1988, Postgraduate medical journal,
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
August 1986, British medical journal (Clinical research ed.),
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
June 1991, Presse medicale (Paris, France : 1983),
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
March 1990, Revista clinica espanola,
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
August 1990, Australian and New Zealand journal of medicine,
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
June 2007, Neurologia (Barcelona, Spain),
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
January 1993, Pediatric research,
B J Brew, and M Perdices, and P Darveniza, and P Edwards, and B Whyte, and W J Burke, and R Garrick, and D O'Sullivan, and R Penny, and D A Cooper
September 1991, Journal of thoracic imaging,
Copied contents to your clipboard!